Profile
Elisabeth Flury is currently the Director of Human Resources at Speedel Pharma AG.
Previously, she worked as the Head of Corporate Finance & Administration at Canyon Pharmaceuticals, Inc.
Elisabeth Flury active positions
Companies | Position | Start |
---|---|---|
Speedel Pharma AG
Speedel Pharma AG Pharmaceuticals: MajorHealth Technology Speedel Pharma AG develops drugs for the treatment of cardiovascular and metabolic diseases. It researches on Renin Inhibitors and also develops an Endothelin Receptor Anatagonist. The company also operates in the U.S. and Japan. It was founded in 1998 and is headquartered in Basel, Switzerland. | Human Resources Officer | - |
Former positions of Elisabeth Flury
Companies | Position | End |
---|---|---|
Canyon Pharmaceuticals, Inc.
Canyon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Canyon Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. Its products include Revasc and Iprivask. The firm produces products to treat various immunity diseases. The company is headquartered in Hunt Valley, MD. | Director of Finance/CFO | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Speedel Pharma AG
Speedel Pharma AG Pharmaceuticals: MajorHealth Technology Speedel Pharma AG develops drugs for the treatment of cardiovascular and metabolic diseases. It researches on Renin Inhibitors and also develops an Endothelin Receptor Anatagonist. The company also operates in the U.S. and Japan. It was founded in 1998 and is headquartered in Basel, Switzerland. | Health Technology |
Canyon Pharmaceuticals, Inc.
Canyon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Canyon Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. Its products include Revasc and Iprivask. The firm produces products to treat various immunity diseases. The company is headquartered in Hunt Valley, MD. | Health Technology |
- Stock Market
- Insiders
- Elisabeth Flury